Kotaro Miyao

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma”.

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma

Frontiers in Pediatrics(2024)10.3389/fped.2023.1305657

N/A

0.464DataRank · unranked

21 citations

James H. Girsch, Elizabeth L. Siegler, Evandro D. Bezerra, Kotaro Miyao, Reona Sakemura +1 more

Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?

Frontiers in Oncology(2023)10.3389/fonc.2022.1082235

N/A

0.330DataRank · unranked

8 citations

Hirofumi Yokota, Reona Sakemura, Kotaro Miyao

Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes

Annals of Hematology(2026)10.1007/s00277-026-06964-8

N/A

0DataRank · unranked

0 citations

Kotaro Miyao, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Hitomi Sawa +3 more